TNF and rheumatoid arthritis: Drugs capable of neutralizing TNF-α, such as etanercept, a fusion protein of soluble TNF-α receptor 2 and IgG1 FC-terminal, have been used clinically to treat diseases such as rheumatoid arthritis and psoriasis37.